Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop

…, NP Quinn, JA Edwardson, PG Ince, C Bergeron… - Neurology, 1996 - AAN Enterprises
Recent neuropathologic autopsy studies found that 15 to 25% of elderly demented patients
have Lewy bodies (LB) in their brainstem and cortex, and in hospital series this may …

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis

M Arbyn, C Bergeron, P Klinkhamer… - Obstetrics & …, 2008 - journals.lww.com
… , E) and conventional cytology (B, D, F) at cutoff high-grade squamous intraepithelial lesion
or worse (A, B), at cutoff low-grade squamous intraepithelial lesion or worse (B, C), and at …

Pathology and physiopathology of adenomyosis

C Bergeron, F Amant, A Ferenczy - … practice & research Clinical obstetrics & …, 2006 - Elsevier
Adenomyosis is defined by the presence of endometrial mucosa within the myometrium.
This probably occurs by invagination of the basalis endometrium into the myometrium. The …

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

…, HTJ Mount, RA Nixon, M Mercken, C Bergeron… - Nature, 2000 - nature.com
Much evidence indicates that abnormal processing and extracellular deposition of amyloid-β
peptide (Aβ), a proteolytic derivative of the β-amyloid precursor protein (βAPP), is central to …

[HTML][HTML] Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695

…, J Paquette, F Gervais, C Bergeron… - Journal of Biological …, 2001 - ASBMB
We have created early-onset transgenic (Tg) models by exploiting the synergistic effects of
familial Alzheimer's disease mutations on amyloid β-peptide (Aβ) biogenesis. TgCRND8 mice …

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration

…, C Bergeron, SS Chin, C Duyckaerts… - … of Neuropathology & …, 2002 - academic.oup.com
A working group supported by the Office of Rare Diseases of the National Institutes of
Health formulated neuropathologic criteria for corticobasal degeneration (CBD) that were …

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

JM Wilson, KS Kalasinsky, AI Levey, C Bergeron… - Nature medicine, 1996 - nature.com
Methamphetamine is a drug that is significantly abused worldwide. Although long–lasting
depletion of dopamine and other dopamine nerve terminal markers has been reported in …

[HTML][HTML] Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

…, PP Bringuier, JY Scoazec, AM Schott, C Bergeron… - PloS one, 2011 - journals.plos.org
Background The exact overall incidence of sarcoma and sarcoma subtypes is not known.
The objective of the present population-based study was to determine this incidence in a …

Ageism and COVID-19: What does our society's response say about us?

…, V Taler, S Adam, M Beaulieu, CD Bergeron… - Age and …, 2020 - academic.oup.com
The goal of this commentary is to highlight the ageism that has emerged during the COVID-19
pandemic. Over 20 international researchers in the field of ageing have contributed to this …

Brain cytochrome oxidase in Alzheimer's disease

SJ Kish, C Bergeron, A Rajput, S Dozic… - Journal of …, 1992 - Wiley Online Library
… other half-brain was frozen at -80C. A detailed neuropathological examination was performed
on all AD cases as previously described (Bergeron and Pollanen, 1989). The criteria for …